Related Experiment Video

Updated: Mar 5, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

1.1K

Is the Future of Coronary Arterial Revascularization a Hybrid Approach?: The Canadian Experience Across Three Centers

Vincenzo Giambruno1, Ahmad Hafiz, Stephanie A Fox

  • 1From the *Division of Cardiac Surgery, Department of Surgery, Western University, London Health Sciences Centre, London, Ontario, Canada; †Division of Cardiac Surgery, University of Montreal, Montreal Heart Institute, Montreal, Quebec, Canada; ‡Division of Cardiac Surgery, University of British Columbia, St. Paul's Hospital, Vancouver, British Columbia, Canada; and §Division of Cardiology, Department of Medicine, ∥Department of Anesthesia and Perioperative Medicine, Western University, London Health Sciences Centre, London, Ontario, Canada.

Innovations (Philadelphia, Pa.)
|March 25, 2017
PubMed

Insights

Hybrid coronary revascularization combines surgical and percutaneous approaches, demonstrating excellent graft and stent patency. This safe strategy offers selected patients complete revascularization with minimal trauma and favorable long-term outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Minimally Invasive Procedures

Background:

  • Hybrid coronary revascularization integrates surgical and percutaneous interventions to leverage their respective advantages.
  • This approach aims to overcome the limitations inherent in isolated surgical or percutaneous coronary revascularization techniques.

Purpose of the Study:

  • To evaluate graft and stent patency at 6 months post-procedure.
  • To assess bleeding rates, intensive care unit (ICU) and hospital length of stay.
  • To determine rates of reintervention and long-term clinical outcomes following hybrid coronary revascularization.

Main Methods:

  • A total of 203 patients underwent robotic-assisted minimally invasive direct coronary artery bypass graft (MIDCAB) of the left internal thoracic artery (LITA) to the left anterior descending (LAD) artery and percutaneous coronary intervention (PCI) of a non-LAD vessel.
  • Procedures were performed in a single or two stages across three centers between March 2004 and November 2015.
  • Patients received 6-month angiographic follow-up and a mean clinical follow-up of 77.82 ± 41.4 months.

Main Results:

  • Successful hybrid coronary revascularization was achieved in 196 out of 203 patients (96.6%).
  • Mean ICU stay was 1 ± 1 days, mean hospital stay was 5 ± 2 days, and only 13.3% required blood transfusion.
  • Six-month angiographic follow-up showed LITA anastomotic patency of 97.9% and stent patency of 92.6%. Long-term follow-up revealed 95.1% survival and 90.7% freedom from revascularization.

Conclusions:

  • Hybrid coronary revascularization is a promising and safe strategy for selected patients.
  • It provides functionally complete revascularization with reduced surgical trauma.
  • The procedure is associated with favorable long-term clinical outcomes, including high survival and freedom from angina.
Abstract

More Related Videos

Author Spotlight: Enhancing Coronary Artery Revascularization05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.4K
Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

19.3K

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
352
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
356
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
351